home / stock / morf / morf news


MORF News and Press, Morphic Holding Inc. From 07/08/24

Stock Information

Company Name: Morphic Holding Inc.
Stock Symbol: MORF
Market: NASDAQ
Website: morphictx.com

Menu

MORF MORF Quote MORF Short MORF News MORF Articles MORF Message Board
Get MORF Alerts

News, Short Squeeze, Breakout and More Instantly...

MORF - US Companies Moving the Markets, Morning edition
Mon, Jul 08, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 35.3% to $0.3248 on volume of 164,333,109 shares SRIVARU Holding Limited (SVMH) rose 62.4% to $0.2581 on volume of 68,213,933 shares NVIDIA Corporation (NVDA) rose 2.9% to $129.43 on volume o...

MORF - Eli Lilly to acquire Morphic for $57 a share in cash

2024-07-08 07:05:08 ET In a bid to strengthen its immunology pipeline, Eli Lilly ( NYSE: LLY ) on Monday announced a deal to acquire biopharmaceutical company Morphic Holding ( NASDAQ: MORF ) for $57 a share in cash, or an aggregate of ~$3.2B, payable at closing.... ...

MORF - Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease

Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease PR Newswire Acquisition to expand Lilly's immunology pipeline with oral integrin therapies INDIANAPOLIS and WALTHAM, Mass. , July 8, 2024 /PRNewswire/ -- Eli Lil...

MORF - Morphic to Participate in Jefferies Global Healthcare Conference

WALTHAM, Mass., May 31, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that members of its management team will take part in a fireside c...

MORF - Viking, CRISPR, Intellia among potential M&A targets: Wells Fargo

2024-05-25 10:24:03 ET More on AbbVie, Amgen, etc. Bristol Myers Squibb: 5.5% Yielder Has Been Crushed In What Could Be A Generational Buying Opportunity Why Gilead Sciences' 4.6% Yield Doesn't Make The Cut For Smart Investors Amgen Stock: Poised To Break Out (Techni...

MORF - Morphic Demonstrates Novel Real-Time Visualization of Small Molecule ?4?7 Inhibition of Gut-Trafficking Cells

-α4β7 Inhibition Rapidly Increases the Rolling Velocity and Flux of B Cells in Gut-associated Lymphoid Tissues- -Impact of Potent and Selective Small Molecule Inhibitor Comparable to Monoclonal Antibody Activity- -Preclinical Findings Presented at Digestive Disease...

MORF - Morphic to Participate in RBC Capital Markets Global Healthcare Conference

WALTHAM, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that Dr. Marc Schegerin, COO and CFO, will take part in a fireside...

MORF - (MORF) On The My Stocks Page

2024-05-02 22:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

MORF - Morphic Holding files automatic mixed shelf

2024-04-26 17:34:23 ET More on Morphic Seeking Alpha’s Quant Rating on Morphic Historical earnings data for Morphic Read the full article on Seeking Alpha For further details see: Morphic Holding files automatic mixed shelf

MORF - Morphic GAAP EPS of -$0.91

2024-04-25 07:51:21 ET More on Morphic Seeking Alpha’s Quant Rating on Morphic Historical earnings data for Morphic Financial information for Morphic Read the full article on Seeking Alpha For further details see: Morphic GAAP EPS of -$0.91

Previous 10 Next 10